HealthVentureburn1 day ago
SonoThera Raises $125M to Advance Gene Therapy
4 min read
SonoThera closed a $125 million Series B round led by Vida Ventures. The company is developing a nonviral, ultrasound-mediated platform for gene therapy. The round included strategic investments from Eli Lilly, Bristol Myers Squibb, and Johnson & Johnson Innovation, signaling pharma interest in alternatives to viral vectors.
Level
Hype check
Tap to vote and see what everyone thinks.
